What do you think that signaled about the federal government's approach?

So again, I think one of the wonderful things that a lot of psychedelic researchers have focused on in moving forward psychedelic treatments, particularly MDMA, is focusing on PTSD, which is a really debilitating disorder that affects lots of Americans, lots of people internationally.

But with a special focus on our veterans, a population that I think most Americans would say we would like to help.

They do so much for us.

Let's help them with their mental health condition.

So there were a lot of studies done in those populations to try to convince the government that these drugs had therapeutic benefit.

The recent federal order, I think, is in line with the government's stance on, again, giving several psychedelic drugs breakthrough therapy designation, saying, "Hey, we're going to expediate the approval process if you can provide us quality evidence.

So how have state and federal policies approached this issue of integrating psychedelic agents and psychotherapy?